[go: up one dir, main page]

AU5194496A - 5-HT4 receptor antagonists - Google Patents

5-HT4 receptor antagonists

Info

Publication number
AU5194496A
AU5194496A AU51944/96A AU5194496A AU5194496A AU 5194496 A AU5194496 A AU 5194496A AU 51944/96 A AU51944/96 A AU 51944/96A AU 5194496 A AU5194496 A AU 5194496A AU 5194496 A AU5194496 A AU 5194496A
Authority
AU
Australia
Prior art keywords
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51944/96A
Inventor
Gordon Smith Baxter
Laramie Mary Gaster
Graham Francis Joiner
Alberto Julio Kaumann
Guy Anthony Kennett
Francis David King
Shirley Katherine Rahman
Gareth John Sanger
Kay Alison Wardle
Rodney Christopher Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919117943A external-priority patent/GB9117943D0/en
Priority claimed from GB919119692A external-priority patent/GB9119692D0/en
Priority claimed from GB929201414A external-priority patent/GB9201414D0/en
Priority claimed from GB929203977A external-priority patent/GB9203977D0/en
Priority claimed from GB929208321A external-priority patent/GB9208321D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU5194496A publication Critical patent/AU5194496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU51944/96A 1991-08-20 1996-04-29 5-HT4 receptor antagonists Abandoned AU5194496A (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB919117943A GB9117943D0 (en) 1991-08-20 1991-08-20 Medicaments
GB9117943 1991-08-20
GB919119692A GB9119692D0 (en) 1991-09-14 1991-09-14 Pharmaceuticals
GB9119692 1991-09-14
GB929201414A GB9201414D0 (en) 1992-01-23 1992-01-23 Medicaments
GB9201414 1992-01-23
GB9203977 1992-02-25
GB929203977A GB9203977D0 (en) 1992-02-25 1992-02-25 Pharmaceuticals
GB9208321 1992-04-15
GB929208321A GB9208321D0 (en) 1992-04-15 1992-04-15 Pharmaceuticals

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU24350/92A Division AU2435092A (en) 1991-08-20 1992-08-18 5-ht4 receptor antagonists

Publications (1)

Publication Number Publication Date
AU5194496A true AU5194496A (en) 1996-07-18

Family

ID=27517068

Family Applications (2)

Application Number Title Priority Date Filing Date
AU24350/92A Abandoned AU2435092A (en) 1991-08-20 1992-08-18 5-ht4 receptor antagonists
AU51944/96A Abandoned AU5194496A (en) 1991-08-20 1996-04-29 5-HT4 receptor antagonists

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU24350/92A Abandoned AU2435092A (en) 1991-08-20 1992-08-18 5-ht4 receptor antagonists

Country Status (8)

Country Link
EP (1) EP0600955A1 (en)
JP (1) JPH06510283A (en)
AU (2) AU2435092A (en)
CA (1) CA2116024A1 (en)
MX (1) MX9204786A (en)
NZ (1) NZ243993A (en)
PT (1) PT100785A (en)
WO (1) WO1993003725A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
JPH07507290A (en) * 1992-05-23 1995-08-10 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Medications for the treatment of anxiety disorders
JPH07508276A (en) * 1992-06-27 1995-09-14 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Pharmaceutical products containing 5-HT↓4 receptor antagonists
US5726187A (en) * 1992-10-16 1998-03-10 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
ES2056728B1 (en) * 1992-10-28 1995-05-01 Smithkline Beecham Plc NEW PIPERIDILE AND AMINOALKYL DERIVATIVES WITH ANTAGONIST ACTIVITY OF THE 5-HT4 RECEPTOR
NZ257545A (en) * 1992-11-05 1997-01-29 Smithkline Beecham Plc Heterocyclic (especially piperidine) derivatives and pharmaceutical compositions
US6127379A (en) * 1993-02-01 2000-10-03 Smithkline Beecham P.L.C. Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
GB9312348D0 (en) * 1993-06-16 1993-07-28 Smithkline Beecham Plc Pharmaceuticals
FR2717174B1 (en) * 1994-03-14 1996-05-31 Sanofi Sa Use of piperidinoethyl esters of 4-amino-5-chloro-2-methoxybenzoic acid as 5-HT4 agonists.
AU2075295A (en) * 1994-03-14 1995-10-03 Sanofi Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists
EP0683161A1 (en) * 1994-05-17 1995-11-22 MIDY S.p.A. Ester of 4-amino-5-chloro-2-methoxybenzoic acid, process for their preparation and pharmaceutical compositions containing them
WO1996005166A1 (en) * 1994-08-11 1996-02-22 Yamanouchi Pharmaceutical Co., Ltd. Substituted amine derivative and medicinal composition containing the same
RU2154064C2 (en) * 1994-09-27 2000-08-10 Жансен Фармасетика Н.В. N-substituted piperidinylbenzoates, their n-oxide forms, pharmaceutically acceptable salts of additive acid salts and stereochemically isomeric forms, methods of their synthesis, pharmaceutical composition based on thereof and intermediate substance
JP3862750B2 (en) * 1994-09-27 2006-12-27 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Phenyl-oxo-alkyl- (4-piperidinyl) benzoate derivatives
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
CA2222532A1 (en) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Indazole derivatives having monocyclic amine
FR2741069B1 (en) * 1995-11-09 1997-12-12 Synthelabo 5-PHENYL-3- (PIPERIDIN-4-YL) -1,3,4-OXADIAZOL-2 (3H) -ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
EE03487B1 (en) * 1995-11-09 2001-08-15 Synthlabo 5-Phenyl-3- (piperidin-4-yl) -1,3,4-oxadiazol-2 (3H) -one Derivatives for Use as Ligands for 5-HT 4 or H 3 Receptors
TW445263B (en) 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
IT1291569B1 (en) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolamides as serotonergic agents
TW548103B (en) 1997-07-11 2003-08-21 Janssen Pharmaceutica Nv Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
FR2766484B1 (en) * 1997-07-25 1999-09-17 Logeais Labor Jacques NOVEL STIMULATING BENZAMIDE DERIVATIVES OF HIGH AND LOW GASTROINTESTINAL MOTORITY
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
TR200100698T2 (en) * 1998-09-10 2001-07-23 F.Hoffmann-La Roche Ag Dihydrobenzodioxin Carboxamide and Ketone derivatives as 5-HT4 receptor-Antagonists
ID29067A (en) * 1998-11-20 2001-07-26 Hoffmann La Roche PIROLIDINA-ANTAGONIS RECIPTORS DOWN CCR-3
TW570920B (en) 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
FR2821356A1 (en) * 2001-02-23 2002-08-30 Cerep NOVEL ARYLCARBAMATE AND ARYLUREES DERIVATIVES, PREPARATIONS AND USES
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
ITMI20031468A1 (en) * 2003-07-18 2005-01-19 Acraf ATIVE DRUG IN NEUROPATHIC PAIN
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7396933B2 (en) 2004-11-05 2008-07-08 Theravance, Inc. Quinolinone-carboxamide compounds
DE602005016446D1 (en) 2004-11-05 2009-10-15 Theravance Inc 5-HT4 receptor agonist compounds
DE602005021696D1 (en) 2004-12-22 2010-07-15 Theravance Inc INDAZOLCARBONSÄUREAMIDVERBINDUNGEN
CN101163701A (en) 2005-03-02 2008-04-16 施万制药 Quinolinone compounds as 5-HT 4 receptor agonists
FR3006686A1 (en) * 2013-06-05 2014-12-12 Univ Caen ACETYLCHOLINESTERASE INHIBITOR COMPOUNDS AND PROMOTING EFFECT OF 5HT4 SEROTONINERGIC RECEPTOR AGONISTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (en) * 1982-06-29 1988-03-10 Sandoz Ag FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA ALKYLENOEVERBRYGGADE PIPERIDYLESTRAR ELLER -AMIDER AV BICYKLISKA KARBOXYLSYROR.
CY1908A (en) * 1984-12-20 1985-12-13 Sandoz Ag Treatment of gastrointestinal disorders using 5-HT3 antagonists
EP0498466B1 (en) * 1985-04-27 2002-07-24 F. Hoffmann-La Roche Ag Indazole-3-carboxamide and -3-carboxylic acid derivatives
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
EP0600955A1 (en) 1994-06-15
PT100785A (en) 1994-04-29
AU2435092A (en) 1993-03-16
JPH06510283A (en) 1994-11-17
CA2116024A1 (en) 1993-03-04
MX9204786A (en) 1993-04-01
WO1993003725A1 (en) 1993-03-04
NZ243993A (en) 1994-10-26

Similar Documents

Publication Publication Date Title
AU5194496A (en) 5-HT4 receptor antagonists
AU2363492A (en) 5-ht4 receptor antagonists
AU8374491A (en) Angiotensin II receptor antagonists
AU5873594A (en) Endothelin receptor antagonists
AU3665793A (en) Fibrinogen receptor antagonists
AU7692996A (en) Receptor antagonists
AU4679793A (en) Endothelin receptor antagonists
AU4396193A (en) 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
AU8477891A (en) Fibrinogen receptor antagonists
HU9401319D0 (en) Endothelin receptor antagonists
AU1441695A (en) Fibrinogen receptor antagonists
FI941178L (en) 5-HT4 receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
IL111431A0 (en) Endothelin receptor antagonists
AU3276293A (en) Angiotensin II receptor antagonists
IL109443A0 (en) Endothelin receptor antagonists
AU4261293A (en) 1-piperazineacetic derivatives as fibrinogen receptor antagonists
AU8081894A (en) Non-steroid androgen receptor antagonists
ZA937505B (en) Imidazopyridine derivatives as 5-HT4 receptor antagonists
AU1919992A (en) Angiotensin ii receptor antagonist thiazole devivatives
AU5322994A (en) Fibrinogen receptor antagonists
AU2296092A (en) Muscarinic antagonists
HU9501073D0 (en) Benzofuran derivatives as 5-hti-like receptor antagonists
AU4350493A (en) Medicaments containing 5-ht4 receptor antagonists
AU3769089A (en) Alpha-adrenergic receptor antagonists